Berenberg Bank reaffirms Smith & Nephew’s “buy” rating: 4 takeaways

Berenberg Bank reaffirmed its “buy” rating on Smith & Nephew’s stock, according to a Financial Market News report.

Advertisement

Here are four takeaways:

 

1. Berenberg Bank currently has an $18.74 price target on the stock.

 

2. The company has a 50-day moving average of $1263.52 and a 200-day moving average of $1266.74.

 

3. Smith & Nephew has a one-year low of $1121.66 and a one-year high of $1356.65.

 

4. The stock’s market cap is $10.85 billion.

 

More articles on devices:
First Mercantile Trust buys additional Globus Medical shares: 5 points
5 things to know about Integra LifeSciences Holdings shares
Analysts expect Exactech shares to rise — 4 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.